Virtu Financial’s Chembio diagnostics, Inc. CEMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-143,265
Closed -$63K 2447
2023
Q1
$63K Buy
143,265
+62,646
+78% +$24.6K 0.01% 1064
2022
Q4
$18K Buy
+80,619
New +$24.1K ﹤0.01% 1293
2022
Q2
Sell
-37,077
Closed -$30K 2418
2022
Q1
$30K Sell
37,077
-82,161
-69% -$76.6K ﹤0.01% 1240
2021
Q4
$136K Buy
119,238
+99,585
+507% +$203K 0.01% 994
2021
Q3
$49K Buy
+19,653
New +$54.5K ﹤0.01% 1283
2021
Q1
Sell
-62,001
Closed -$295K 2380
2020
Q4
$295K Buy
+62,001
New +$320K 0.03% 648
2020
Q3
Sell
-82,976
Closed -$270K 1822
2020
Q2
$270K Buy
+82,976
New +$788K 0.03% 593
2018
Q1
Sell
-11,133
Closed -$91K 3108
2017
Q4
$91K Buy
+11,133
New +$75.4K ﹤0.01% 1941

Other funds holding CEMI

Virtu Financial's CEMI Position: Q2 2023 in Review

Virtu Financial sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2023, closing a stake of 143,265 shares — an estimated $63K sold.

Virtu Financial first reported a position in CEMI in Q4 2017 and held it in 8 quarters. The position peaked at $295K in Q4 2020. 1 fund tracked by Wall St. Rank holds CEMI as of Q2 2023.

  • Virtu Financial reported no remaining Chembio diagnostics, Inc. position as of Q2 2023 after selling out during the quarter.
  • Virtu Financial sold 143,265 Chembio diagnostics, Inc. shares in Q2 2023, an estimated $63K.
  • Virtu Financial first reported a position in Chembio diagnostics, Inc. in Q4 2017 and held it in 8 quarters.
  • Virtu Financial's Chembio diagnostics, Inc. position peaked at $295K in Q4 2020.
  • 1 fund tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2023.

Based on Virtu Financial's 13F filing for Q2 2023, filed 27 Jul 2023.